Page 2 - Activity Score News Today

An anti-IGF-1R antibody VRDN-001developed by Viridian Therapeutics has succeeded in a phase I/II clinical trial of people with active thyroid eye disease, with participants seeing an average 2.4 mm...

Characterizing the clinical presentation, factors associated and determining disease severity among participants with Rheumatoid Arthritis. Read more

Here’s what I learned and concluded after my five-week Oura Ring trial.

Here’s what I learned and concluded after my five-week Oura Ring trial.

Study IDs factors predicting response to TNF inhibitors

For well under $100, Amazon's Halo View health tracker is an excellent tool to help-kick start your fitness journey.

All Specs Lots of fitness trackers can measure your calories burned, heart rate, and steps. With the Halo, Amazon wants to give you greater visibility into your overall health, along with actionable insights to help improve it. Priced at $99.99 for the band plus $3.99 per month for a membership (after a six-month free trial), the Halo does an excellent job of monitoring your activity and sleep, and its companion app gives you access to a wide range of workouts and wellness programs. In additio...

Okay, first impressions: The ring takes a few minutes to set up. Once you pair it to your smart device via the free Oura app , youre prompted to answer a few questions, such as your height, weight, and current goals. I chose the somewhat broad "Improve my health," but other options include "Be productive and energetic" and "Manage stress levels." From there, you slip the ring onto your finger — any digit is doable, though index, middle, or ring tend to work best, according to the brand — a...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 ... ChemoCentryx, Inc.December 21, 2020 GMT As in ANCA vasculitis, avacopan demonstrated statistically significant improvement in renal function as measured by eGFR compared to placebo over 26 weeks of blinded treatment The change from baseline to Week 26 in C3 Glomerulopathy Histologic Index (C3G HI) for Disease Act...

Share: As in ANCA vasculitis, avacopan demonstrated statistically significant improvement in renal function as measured by eGFR compared to placebo over 26 weeks of blinded treatment The change from baseline to Week 26 in C3 Glomerulopathy Histologic Index (C3G HI) for Disease Activity (primary endpoint) was not statistically different between the two treatment groups, while the C3G HI for Disease Chronicity (measuring progression of fibrosis) shows significant benefit for avacopan versus place...